Biopharma News

Sep 26, 2017
By BioPharm International Editors
This latest FDA approval expands the blockbuster anti-cancer biologic’s indications in oncology.
Sep 25, 2017
By BioPharm International Editors
The collaboration will evaluate the combination of BMS’ Opdivo immunotherapy with an investigational antibody drug conjugate in development by AbbVie.
Sep 20, 2017
By BioPharm International Editors
Under this partnership, Johnson & Johnson and BARDA will focus on the advanced development of a small-molecule drug and vaccine for the pandemic flu.
Sep 19, 2017
By BioPharm International Editors
The partners will develop a lead anti-platelet, anti-coagulant (APAC) product for treating blood vessel wall injury. Clinical trials are set for 2019 in India.
Sep 19, 2017
By BioPharm International Editors
The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases.
Sep 15, 2017
By BioPharm International Editors
European Medicines Agency’s Committee for Medicinal Products for Human Use grants a positive opinion for the approval of the biosimilar for treating breast cancer.
Sep 15, 2017
By BioPharm International Editors
The approval marks the first biosimilar approved in the United States for treating cancers.
Sep 14, 2017
By BioPharm International Editors
Shingrix represents a new, possibly better alternative to existing treatments.
Sep 14, 2017
By BioPharm International Editors
Focused around Purdue University’s LyoHUB, a new blueprint aims to bring innovation to equipment and processes. One goal? Continuous freeze drying.
Sep 12, 2017
By BioPharm International Editors
Alexion’s restructuring will reduce its global workforce by 20%, including closing a manufacturing facility in Rhode Island.
native1_300x100
lorem ipsum